Antidepressant Treatment and Manic Switch in Bipolar I Disorder: A Clinical and Molecular Genetic Study

被引:7
|
作者
Chen, Chih-Ken [1 ,2 ,3 ]
Wu, Lawrence Shih-Hsin [4 ]
Huang, Ming-Chyi [5 ,6 ]
Kuo, Chian-Jue [5 ,6 ]
Cheng, Andrew Tai-Ann [4 ,7 ]
机构
[1] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung 204, Taiwan
[2] Chang Gung Mem Hosp, Dept Psychiat, Keelung 204, Taiwan
[3] Chang Gung Univ, Coll Med, Taoyuan 333, Taiwan
[4] China Med Univ, Grad Inst Biomed Sci, Taichung 404, Taiwan
[5] Taipei City Hosp, Dept Gen Psychiat, Taipei City Psychiat Ctr, Taipei 10341, Taiwan
[6] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei 106, Taiwan
[7] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 04期
关键词
bipolar I disorder; bipolar depression; antidepressant treatment; manic switch; genome-wide association study; TASK-FORCE REPORT; INTERNATIONAL SOCIETY; GENOTYPE IMPUTATION; LITHIUM TREATMENT; RECEPTOR-BINDING; DEPRESSION; ASSOCIATION; RISK; PHARMACOGENOMICS; METAANALYSIS;
D O I
10.3390/jpm12040615
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Affective switch is an important clinical issue when treating bipolar disorder. Though commonly seen in clinical practice, the benefits of prescribing antidepressants for bipolar depression are still controversial. To date, there have been few genetic studies and no genome-wide association study (GWAS), focusing on manic switch following bipolar depression. This study aims to investigate the effects of individual genomics and antidepressant medication on the risk of manic switch in bipolar I disorder (BPI). A total of 1004 patients with BPI who had at least one depressive episode with complete data on antidepressant treatment and outcome were included. Clinical assessment of mania and depression was performed by trained psychiatric nurses and psychiatrists using the Chinese version of the Schedules for Clinical Assessment in Neuropsychiatry (SCAN), and the diagnosis of BPI was made according to DSM-IV criteria. Manic switch was defined as a manic episode occurring within eight weeks of remission from an acute depressive episode. The age at first depressive episode of the study patients was 30.7 years (SD 12.5) and 56% of all patients were female. GWAS was carried out in a discovery group of 746 patients, followed by replication in an independent group of 255 patients. The top SNP rs10262219 on chromosome 7 showed the strongest allelic association with manic switch (p = 2.21 x 10(-7)) in GWAS, which was however not significantly replicated. Antidepressant treatment significantly (odds ratio 1.7; 95% CI 1.3-2.2; p < 0.001) increased the risk of manic switch. In logistic regression analysis, the CC genotype of rs10262219 (odds ratio 3.0; 95% CI 1.7-5.2) and antidepressant treatment (odds ratio 2.3; 95% CI 1.4-3.7) significantly increased the risk of manic switch with a joint effect (odds ratio 5.9; 95% CI 3.7-9.4). In conclusion, antidepressant medication and rs10262219 variants jointly increased the risk of manic switch after bipolar depression.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Clinical characteristics of antidepressant use and related manic switch in bipolar disorder
    Berkol, Tonguc D.
    Balcioglu, Yasin H.
    Kirlioglu, Simge S.
    Ozarslan, Zengibar
    Islam, Serkan
    Ozyildirim, Ilker
    [J]. NEUROSCIENCES, 2019, 24 (01) : 45 - 52
  • [2] Sociodemographic and Clinical Features of Antidepressant-Induced Hypomanic and Manic Switch in Patients with Bipolar Disorder
    Sarisoy, Gokhan
    Pazvantoglu, Ozan
    [J]. DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2013, 26 (02): : 122 - 130
  • [3] Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder
    Serretti, A
    Artioli, P
    Zanardi, R
    Rossini, D
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (05): : 751 - 757
  • [4] A smaller percentage of unipolar depression patients with manic or hypomanic switch during acute antidepressant treatment convert to bipolar disorder
    Wada, Ken
    Iwamoto, Takashi
    Kurata, Akiko
    Sakane, Katsuaki
    Takenoshita, Shintaro
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 66 - 67
  • [5] Predictors for manic switch at depressive episodes in bipolar disorder: the Systematic Treatment Enhancement Program for Bipolar Disorder
    Niitsu, T.
    Fabbri, C.
    Serretti, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S431 - S432
  • [6] Clinical and genetic features of antidepressant induced mania in bipolar disorder
    Artioli, P
    Serretti, A
    Lattuada, E
    Lorenzi, C
    Lilli, R
    Smeraldi, E
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 755 - 755
  • [7] Risk of Manic Switch Associated with Antidepressant Therapy in Pediatric Bipolar Depression
    Bhowmik, Debajyoti
    Aparasu, Rajender R.
    Rajan, Suja S.
    Sherer, Jeffrey T.
    Ochoa-Perez, Melissa
    Chen, Hua
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (10) : 551 - 561
  • [8] Predictors of manic switch with antidepressant treatment in unipolar depression
    Dumlu, K
    Özerdem, A
    Arkar, H
    Tunca, Z
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S443 - S443
  • [9] Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice
    Fagiolini, Andrea
    Forgione, Rocco N.
    Morana, Benedetto
    Maccari, Mauro
    Goracci, Arianna
    Bossini, Letizia
    Pellegrini, Francesca
    Cuomo, Alessandro
    Casamassima, Francesco
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (04) : 489 - 504
  • [10] Manic-Depressive Cycles in Bipolar Disorder: Clinical and Treatment Implications
    Teobaldi, Elena
    Albert, Umberto
    Di Salvo, Gabriele
    Mencacci, Claudio
    Rosso, Gianluca
    Salvi, Virginio
    Maina, Giuseppe
    [J]. PSYCHOPATHOLOGY, 2021, 54 (02) : 98 - 105